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ABSTRACT
The green fluorescent protein (GFP) is currently being
used for diverse cellular biology approaches, mainly
as a protein tag or to monitor gene expression.
Recently it has been shown that GFP can also be used
to monitor the activation of second messenger path-
ways by the use of fluorescence resonance energy
transfer (FRET) between two different GFP mutants
fused to a Ca2+ sensor. We show here that GFP fusions
can also be used to obtain information on regions
essential for protein function. As FRET requires the
two GFPs to be very close, N- or C-terminal fusion
proteins will not generally produce FRET between two
interacting proteins. In order to increase the probability
of FRET, we decided to study the effect of random
insertion of two GFP mutants into a protein of interest.
We describe here a methodology for random insertion
of GFP into the cAMP-dependent protein kinase
regulatory subunit using a bacterial expression vector.
The selection and analysis of 120 green fluorescent
colonies revealed that the insertions were distributed
throughout the R coding region. 14 R/GFP fusion
proteins were partially purified and characterized for
cAMP binding, fluorescence and ability to inhibit PKA
catalytic activity. This study reveals that GFP insertion
only moderately disturbed the overall folding of the
protein or the proper folding of another domain of the
protein, as tested by cAMP binding capacity.
Furthermore, three R subunits out of 14, which harbour
a GFP inserted in the cAMP binding site B, inhibit PKA
catalytic subunit in a cAMP-dependent manner. Random
insertion of GFP within the R subunit sets the path to
develop two-component FRET with the C subunit.
INTRODUCTION
Since it was first cloned in 1992 (1), the green fluorescent protein
(GFP) from the jellyfish Aequorea victoria has been used in many
in vivo cell biology approaches to monitor the localization of GFP
fused to proteins of interest (2) or promoter activation (3). The
versatility of this technique has been enlarged by the production
of multiple mutants with different fluorescence spectra (4). The
green fluorescence of GFP was recently extended to monitor
physiological changes as an indirect or direct measure of enzyme
activities. Thus, constructs have been developed to produce
fusion proteins where two GFPs, a donor and an acceptor with
overlapping absorption and emission spectra, allow to sense
intracellular Ca2+ levels by means of fluorescence resonance
energy transfer (FRET) changes (5,6). The appearance or
disappearance of FRET reflects the distance (d) between the
GFPs since FRETs efficiency decreases as a function of d6.
PKA is composed of regulatory (R) and catalytic (C) subunits
which associate in an inactive holoenzyme. The R subunit has two
cAMP binding sites named site A and site B, which display different
binding properties towards cAMP (7). Upon binding of cAMP to the
R subunit, the holoenzyme dissociates, liberating active C subunits.
PKA thus represents a sensitive indicator of intracellular cAMP
levels. By microinjecting purified mammalian R and C subunits
labelled with two different chemical fluorochromes, PKA was used
to follow changes in intracellular cAMP concentration in vivo by
FRET disappearance upon stimulation of smooth muscle and
fibroblast cell lines with β-adrenergic agonists or prostaglandin E1
(8).
In Dictyostelium, PKA is also made of R and C subunits.
However, both subunits display some structural differences with
their mammalian counterparts. The R subunit lacks a dimerization
domain present at the N-terminus of mammalian regulatory
subunits and accordingly, the holoenzyme forms an RC dimer
rather than the usual R2C2 tetramer (9). The C subunit has an
additional domain at its N-terminus whose function begins to be
established (10,11).
FRET between two different GFPs fused with the R and C
subunits when the subunits are associated within the holoenzyme
would be of obvious interest, both to measure in vivo variations
of intracellular cAMP concentrations and to analyse the state of
dissociation of the holoenzyme in various physiological conditions.
However, N- or C-terminus GFP fusions did not bring the GFPs
into close proximity so that FRET can occur. To avoid this
problem, we decided to insert GFPs at random inside the coding
region of the PKA R subunit from Dictyostelium. Here we
describe the methodology used to produce these random insertions
and the analysis of some of the R/GFP fusion proteins. The
modification of the biochemical properties of certain R/GFP
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fusion proteins indicate that such insertions can provide useful
functional mapping information.
MATERIALS AND METHODS
Materials
The plasmid pRSETb-R was described previously (10). Escherichia
coli strain BL21 (DE3) was from Stratagene. Restriction and
modification enzymes used were from Boehringer Mannheim,
Promega, Pharmacia or Gibco. NTPs and protease inhibitor
cocktail were from Boehringer Mannheim. CsCl was from
Sigma. Monoclonal anti-His-tag antibodies were from Qiagen.
Monoclonal antibodies anti-R111, from cell culture supernatants,
were a kind gift of Prof. Gerisch (Max Planck Institut, Martinsried,
Germany). [3H]cAMP, the ECL chemioluminescence kit used for
western blot detection and 125I-labelled secondary antibody used
for protein quantification were from Amersham. Western blot
quantification results were analysed using an Instant-Imager
(Packard). Prestained protein molecular weight standards for
SDS–PAGE (high) were from Gibco. The fluorescence microscope
used for screening was an inverse Axiovert 25 (Zeiss) microscope
with BP 450–490 excitation filter, beamsplitter FT510 and BP
515–565 emission filter (Zeiss). Fluorescence spectra were
obtained with a PTI equipment and data were processed using
Felix software. Plasmids containing S65T and W7 GFP mutant
proteins, used as templates for PCR, were kindly provided by
Dr R.Y.Tsien (University of California, San Diego, CA).
pRSETb-R/GFP library
The methodology used for the construction of the R/GFP library
is similar to that described (12). Nicks were first introduced in
supercoiled pRSETb-R by a controlled DNase I treatment under
conditions for nick translation to take place and then submitted to
nuclease S1 digestion before addition of linkers and GFP
fragments. In preliminary assays, supercoiled pRSETb-R plasmid
(25 µg) was incubated in 1× DNA pol I buffer (Promega) at 15C
with 5 pg DNase I in a final volume of 50 µl. In order to evaluate
the extent of the appearance of nicked circular plasmids, aliquots
from different incubation times (0, 15, 30 and 45 min) were
subjected to electrophoresis on 0.9% agar gels in TAE buffer for
3–5 h at constant voltage (50 V). Incubation times were chosen
so that 30–50% of the plasmids were nicked. In the preparative
experiment, all volumes were increased 25 times and the reaction
mixture was equilibrated at 15C in the presence of 75 µM of
each dNTP and 400 U DNA pol I. The reaction was then initiated
by the addition of DNase I and stopped after 15 min with EDTA
(25 mM final concentration). After CsCl gradient centrifugation
to purify nicked circular plasmids, incubation times with nuclease
S1 were also chosen so that ≤50% of the plasmids were linearized.
Longer incubation times did not increase substantially the appear-
ance of linearized plasmids, suggesting that nuclease S1 was mostly
acting on already linear plasmids producing deletions, rather than on
nicks. The ends of the linearized plasmids were filled using T4 DNA
polymerase to produce blunt ends to which SalI linkers (gtcgac)
were ligated. Either S65T or W7 GFP (4) fragments were amplified
by 30 cycles of PCR using the primers 5′-CCCGTCGTCGACATG-
AGTAAAGGAGAAGAA-3′ and 5′-AGTCGGGTCGACTTTG-
TATAGTTCATCCATGCC-3′ with 1 min incubations at 95, 45
and 74C for melting, annealing and elongation, respectively.
Finally, SalI-digested plasmids and PCR fragments were ligated
and plasmids were transformed in E.coli BL21 (DE3) by
electroporation.
Functional screening of green fluorescent fusion proteins
Clones producing R/GFP fusion proteins were screened for
fluorescence on agar plates, either directly by eye observation in
daylight or using an inverted microscope with fluorescein filters.
Approximately 2–5 × 105 colonies were screened, allowing us to
isolate 120 clones showing pRSETb-R/GFP fusions as seen by
restriction mapping using either EcoRI to verify for the insertion
of GFP or the combination of XhoI/SalI or HindIII/SalI to localize
the approximate site of insertion.
In order to identify the GFP insertion sites within the R subunit
sequence, two primers from the GFP coding regions were designed
and used to sequence in the 3′ and 5′ direction from the GFP gene.
The primers used were 5′-GCTGCTGGGATTACACA-3′ and
5′-TAACATCACCATCTAAT-3′.
Fluorescence spectra
The assay was performed at 20C using variable amounts of total
cell suspensions or partially purified proteins in 50 mM Tris–HCl,
pH 7.5. Bandwidths were kept constant at 6 nm. Integration time
was usually 0.2 s. Excitation and emission wavelengths used for
GFP S65T were 490 and 510 nm and 450 and 510 nm for GFP W7.
Partial purification of R/GFP fusion proteins
Cells were grown at 37C until OD600 0.3–0.6, induced for
expression of the fusion protein with the addition of 1 mM IPTG
and further incubated overnight at 22C. R/GFP purifications
were performed at 4C. The cells from 500 ml cultures were
broken in a French press in buffer A (50 mM Tris–HCl, pH 7.5,
100 mM NaCl, 0.1 mM DTT) in the presence of protease inhibitor
cocktail. The extracts were immediately incubated with 0.5 ml
Ni–agarose resin for 1 h. The resins were then loaded into
columns and washed with 10 vol 5 mM imidazole in buffer A. In
order to strip R subunits from any bound cAMP, the columns were
washed with 5 vol 5 mM cGMP in buffer A at 0.5 ml/h, left
overnight in the presence of cGMP and then extensively washed
again with 5 mM imidazole in buffer A to remove cGMP. R/GFP
fusion proteins were eluted using 100 mM imidazole in buffer A
and extensively dialysed against buffer A to remove imidazole.
R/GFP concentration in most of the partially purified samples
was quantified by western blot using anti-R111 monoclonal
antibody and 125I-labelled secondary antibody; an instant imager
was used to measure radioactivity associated with each band. For
R/GFP 16 and R/GFP 106, quantification was performed on
Coomassie blue stained SDS–PAGE gels. We estimated that this
quantification was accurate within 30%, which was sufficient for
the purpose of the experiments reported here.
cAMP binding assay
cAMP binding assays were performed using the ammonium
sulphate precipitation assay as described (13). Variable amounts of
bacterial extracts or partially purified samples were incubated in a
final volume of 100 µl containing 50 mM Tris–HCl, pH 6.8,
100 mM KCl, 100 µg/ml BSA, 1 mM DTT and 50 nM cAMP
(45 µCi/nmol) unless otherwise indicated. Separation between free
and bound cAMP was performed by filtration (13) after 2 h
incubation on ice (4C). The amount of crude extract or partially
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purified protein used in a given assay was adjusted so that the
binding was linear with the amount of sample used. For partially
purified proteins, the measured radioactivity was at least 3-fold
above background. For most clones, however, the specific binding
measured was between 10 and 20 times background (Table 2). The
specificity of the binding was indicated by the fact that when
1 mg/ml BSA and 5′-AMP (at a concentration 10× greater then
cAMP) were added to the incubation mixture, no difference in
cAMP binding was found. Duplicates in a given experiment agreed
within 20%.
PKA activity assay
Cells were grown at 37C until OD600 0.3–0.6, induced for
expression of fusion protein by addition of 1 mM IPTG and
further incubated for 4 h at 28C. An equivalent of 1 OD of cells
were lysed at 4C in 100 µl of HMN (50 mM HEPES, 40 mM
MgCl2, 20 mM NaCl, 0.5% NP-40) in the presence of protease
inhibitors. For the extract of C309 (truncated version of the
Dictyostelium C subunit), DEAE–Sephacel (Pharmacia) was
added and binding was performed at 4C for 30 min. After
centrifugation, PKA C was eluted in high salt buffer (HMN with
200 mM KCl) at 4C for 5 min.
PKA activity was measured using the PepTag kit from
Promega with fluorescent peptide LRRASLG (derived from
Kemptide) as a substrate according to the manufacturer’s
instructions. C and R subunits were mixed with or without cAMP.
Enzymatic reactions were carried out at 20C for 45 min.
Phosphorylation by PKA alters the net charge of Kemptide from
+1 to –1, so that the phosphorylated peptide can be separated from
the unphosphorylated on buffered agarose gels.
RESULTS AND DISCUSSION
The methodology used for random insertion of GFP is a variation
from that used by Luckow et al. (12) to make linker scanning
mutants in the promoter of the chicken lysozyme gene. We
produced nicks in the vector by incubating the PKA R expression
plasmid along with DNase I, DNA pol I and dNTPs under the
conditions where nick translation takes place. Then, a nuclease S1
treatment at pH 5.7 was used to linearize the plasmid at the
position of the nicks. SalI linkers were inserted and the plasmids
were cut before cloning either S65T or W7 GFP mutants therein.
After transforming BL21 (DE3) E.coli cells, green colonies were
identified directly on agar plates and isolated. GFP insertion was
verified by SalI digestion of the purified plasmids. Using
XhoI/SalI and HindIII/SalI digestions, we determined the
approximate site of insertion of the GFP within plasmid
pRSETb-R. About 50% of the plasmids showed GFP inserted
outside of the R coding sequence, possibly due to the expression
of GFP/AmpR fusion proteins. These clones were not further
characterized.
One hundred and twenty clones with GFP inserted within the
R subunit coding region were isolated. As shown in Figure 1,
insertions occurred throughout the R coding sequence, indicating
that the methodology indeed resulted in the random insertion of
nicks. Since the colonies were selected on the basis of their green
fluorescence, we expected GFP to be fused in-frame with the R
coding sequence in all of the 120 clones shown in Figure 1. This
does not preclude that the sequence of the R subunit located
downstream of the GFP would be out of frame, due to small
deletions that could have occurred during the nuclease S1 digestion.
Figure 1. Location of the GFP insertion sites in R/GFP fusion plasmids. (A) A
scheme of the Dictyostelium R subunit shows the position of the putative
pseudo-substrate region (PS) and the cAMP binding sites A and B. For the sake
of simplicity, the N-terminal His tag and enterokinase recognition sequence
from plasmid pRSET-B (Invitrogen) are not shown. (B) To calculate the
position of the GFP insertion site, purified plasmids were digested with
combinations of two restriction enzymes, SalI/XhoI and SalI/HindIII, and
separated by 1% agarose electrophoresis in TBE buffer. The position of the
insertion sites were then calculated based on the size of the bands. The error on
GFP insertion site was mostly found to be <50 bp. One hundred and seven
individual R/GFP clones are represented; a black box comprising 40 nt shows
the approximate GFP insertion site on each R/GFP clone.
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Figure 2. Western blot analysis of R/GFP green fluorescent clones. Extracts
from 14 representative clones were separated by 12% SDS–PAGE. R/GFP
fusion proteins were recognized by western blot with anti-His-tag antibodies.
Clones with bands at 70–75 kDa were selected as potential in-frame constructs.
The molecular weight markers are shown at the left side. The number on top
of each lane refers to the corresponding R/GFP clone.
In order to screen for clones where GFP was fused in-frame with
the complete R subunit, we performed western blots on extracts
from the 120 clones. Figure 2 shows the analysis of a representative
sample of clones as revealed using anti-His-tag antibodies. Thirty
five clones showed fusion proteins between 70 and 75 kDa,
approximately the size expected for a fusion between R and GFP
(68 kDa). Typical examples of these are clones 28, 33, 37, 59, 89 and
101. Clones 58 and 91, although apparently also belonging to this
group, were later found to encode truncated proteins at their
C-terminus (below). Anti-R subunit antibodies were also used with
similar results in most of the cases. Occasionally, however, two
different bands were observed when using either anti-His-tag or
anti-R antibodies. This could be due to colony contamination,
degradation or to the presence of mixed plasmids in the original
green fluorescent colony. A typical example is clone 20 for which
anti-R antibodies revealed a band of 75 kDa indicating a full-length
fusion protein (not shown), while a 40 kDa band was more strongly
detected with anti-His-tag antibody (Fig. 2).
To determine the exact location of the GFP insertion, as well as
the extent of deletions produced by the random insertion, we
sequenced 23 clones selected from the western blot analysis. The
site of insertion as well as the extent of the deletion is shown in
Figure 3 for 13 representative clones. We found that the extent of
nucleotide deletions was low, varying in >80% of the cases
(19/23) between 0 and 14 bp; in the remaining clones, deletions
varied from 18 to 39 bp. Ten out of the 23 deletions contained only
A/T nucleotides, corresponding, in total, to 78% of deleted
nucleotides. The fact that in three clones GFP insertions took
place within an exceptional 20 bp stretch of DNA composed of
only A/T nucleotides, further indicated a bias for AT-rich
sequences, which cannot be explained solely by the A/T richness
of the Dictyostelium R sequence (68% A/T). Partial selectivity for
A/T-rich regions could be either due to the nick translation or to
the nuclease S1 treatment. The small deletions were most
probably due to nuclease S1 digestion.
A drawback that we encountered after the screening step was
due to the fact that some of the initially isolated colonies might
have contained more than one plasmid. In addition, the extreme
sensitivity of the GFP detection could have led to the selection of
colonies where GFP could have been expressed in small amounts
even if not in-frame with the R subunit. Thus, retransformation of
R/GFP purified plasmids into BL21 (DE3) cells and reselection of
stable green clones were performed to avoid the carry-over of
unwanted plasmids and to eliminate clones not expressing fusion
proteins. However, two clones escaped this screen and were found
to fluoresce, although sequencing determined the presence of a GFP
out of frame without a Met start codon in the proper reading frame.
We then asked whether the site of insertion could have an
influence on the spectroscopic properties of the GFP. For this,
both absorption and emission fluorescence spectra were recorded
using bacterial cell suspensions of the 14 clones represented in
Figure 2. As shown in Figure 4, in all but one clone, absorption
and emission spectra superimposed with those of GFP S65T and
GFP W7. In clone R/GFP W7-33, however, the emission
spectrum was slightly (∼10%) but significantly modified, showing
a more intense peak at 503 nm than in the W7 GFP control,
indicating a possible influence of this insertion site on GFP
properties. (R/GFP fusion protein clones are either named by the
Figure 3. Determination of the GFP insertion site by sequencing. The insertion sites of 13 representative clones (named by the R/GFP clone numbers on the left) were
ordered by the location of the insertion site. To indicate the position of the insertion site, base pair numbers surrounding the deletions are indicated as superscripts.
Bold upper case characters indicate nucleotides which were deleted upon insertion of GFP. In all clones GFP is in correct reading frame with the R-subunit. In clones
106, 34, 35, 26, 91 and 58, GFP insertion results in a frameshift, leading to stop codons at variable distances downstream from the GFP. The asterisk in clone 106
indicates a position where an adenine base was added after the second SalI restriction site. nd indicates that for this clone, the extent of deletion has not been determined.
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Figure 4. Fluorescence spectra of R/GFPs. Excitation (A) and emission (B) spectra were determined for GFP S65T, GFP W7 and for 15 different R/GFP clones
containing either S65T or W7 GFP. The fluorescence of bacteria in suspension was recorded. In most cases, autofluorescence was negligible. Fluorescence intensity
was normalized so that the highest intensity peaks corresponded to 100%. R/GFP clones shown are: S65T-12, S65T-16, W7-20, W7-26, S65T-28, W7-33, W7-34,
S65T-35, S65T-37, S65T-58, W7-59, W7-89, W7-91, S65T-101, S65T-106.
clone number alone or by the name of GFP inserted followed by
the clone number in cases where specification of the type of GFP
is important, as for example, W7-33). cAMP addition was
without effect on the fluorescent properties of any of the clones
tested. As for fluorescence intensity, R/GFP S65T was in general
found to have a stronger fluorescence than R/GFP W7. When W7
was replaced by S65T in several R/GFP clones, an ∼5–10 times
higher fluorescence intensity was observed in cell suspension
(data not shown). As quantum yields of GFPs S65T and W7 are
very similar (4), this result suggests that GFP W7 has additional
folding constraints or is less stable when present as a fusion
protein. On the other hand, no clear correlation could be
established between the fluorescence intensity and insertion site.
These variations possibly resulted from the sensitivity of GFP to
proper folding dependent on time and temperature.
We then studied the effect of GFP insertion on the cAMP
binding activity of the fusion proteins. In a first step, cAMP
binding assays were performed using crude cell extracts from 93
different R/GFP clones expressing R/GFP fusion proteins. Fifty
seven out of 93 clones had significant cAMP binding (not shown).
At this point it should be noted that ∼65% of the clones had
C-terminal deletions due to frameshifts (above). For this reason,
the lack of cAMP binding in the remaining 36 clones would not
only be due to a conformational effect of GFP insertion into the
cAMP binding site, but also to the deletion of the corresponding
cAMP binding sites. Considering this, we estimated that only 14
clones had lost cAMP binding as a consequence of GFP insertion.
We next performed a more precise cAMP binding character-
ization on 14 clones already presented in Figure 2, for which the
insertion site sequence had been characterized. The R/GFP fusion
proteins were partially purified on Ni–agarose columns as
described in Materials and Methods. In all cases, SDS–PAGE
showed a prominent band corresponding to the fusion protein
which was 10–90% pure, depending on the clone considered (not
shown). The results of the cAMP binding assays are shown in
Tables 1 and  2 for two representative subsets of these clones. The
cAMP binding values were normalized to similar protein
concentrations after estimation of the latter by semi-quantitative
western blots as described in Materials and Methods. Purified
recombinant R subunit (10) was used as control and its cAMP
binding set at 100%.
Table 1 shows the results obtained from clones in which the
insertion of GFP resulted in a frameshift producing C-terminal
deletions in the R subunit. Fusion proteins 16 and 106 showed
very little or no cAMP binding, in accordance with the fact that
their R subunit is deleted upstream from or within the cAMP
binding site A (Fig. 1A gives a schematic representation of the R
subunit). A second group, represented by clones 34, 35 and 26
with a full cAMP binding site A and a completely deleted site B,
showed little variation in cAMP binding, as compared with the
wild-type R subunit. Indeed, it should be noted that our method
to measure protein concentration does not allow a determination
with >30% accuracy.
In order to correlate the biochemical properties of the fusion
proteins with the insertion site of GFP, we built a three-dimensional
model of the two cAMP binding sites of Dictyostelium R subunit,
based on the known structure of the mouse homologue protein
(14). The GFP insertion sites, corresponding to the 11 sequenced
clones comprised in the model, are shown in Figure 5. Interestingly,
highest binding was observed in clones 34, 35 and 26 in the
absence of Tyr197 (the homologue to Trp260 in mouse sequence)
which docks the adenine ring of cAMP bound to site A. This is
similar to the results obtained using a truncated form of bovine RI
subunit, in which domain B was deleted (15). A mutant at this
position was identified to be a dominant inhibitor of PKA by
genetic mapping in RIα of S49 mouse lymphoma cells (16).
Altogether, our results support the model where an aromatic
residue at this position is not necessary for the binding of cAMP
to site A. The dominant inhibitor phenotype of this mutant could
rather be explained if this residue had an important participation
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Table 1. cAMP binding of partially purified R/GFP truncated fusion proteins
1The insertion site is characterized by the last nucleotide or amino acid present before the deletion.
2Approximate molecular weights were estimated from western blots. Note that the estimated molecular
weight of the R/GFP full-length protein is 68 kDa.
3R is the pure recombinant Dictyostelium R subunit.
4Scheme of the R subunit from Dictyostelium and R/GFP fusion proteins. GFP insertion is represented by an
oval (not to scale).
Table 2. cAMP binding of partially purified in-frame R/GFP fusion proteins
1The insertion site is characterized by the last nucleotide or amino acid present before the deletion.
2R is the pure recombinant Dictyostelium R subunit.
3Site of insertion only partially mapped, but the fusion protein has the expected size of 70 kDa.
4Approximate molecular weights were estimated from western blots.
5Scheme of the R subunit from Dictyostelium and R/GFP fusion proteins. GFP insertion is represented by an
oval (not to scale).
in the conformational response of the protein to cAMP binding,
as previously suggested (14).
The full-length fusion proteins (Table 2) showed, overall, a
lower cAMP binding than purified R or truncated fusion proteins
shown in Table 1, possibly linked to folding difficulties of such
multidomain fusion proteins. Insertion of GFP within site A
(clones 28, 59 and 37) significantly lowered cAMP binding as
compared with clones 101 and 33, indicating a preferential
binding of cAMP to site A. Due to the use of 50 nM cAMP we
measured only high affinity binding. Thus these results indicate
that, like in the mouse, the high affinity binding site of the PKA
R from Dictyostelium is site A, which is in accordance with the
high sequence conservation between mouse and Dictyostelium.
We did not attempt to determine precisely the KD of cAMP for
each of the isolated clones. Rather, we compared cAMP binding
at two cAMP concentrations, 50 and 500 nM. No or little increase
in cAMP binding under these two conditions would indicate that
the binding sites were already close to saturation at 50 nM cAMP.
The binding to truncated R/GFP fusions harbouring a functional
site A (clones 34, 35 and 58 in Table 1) increased no more than
2.3 times, indicating a high affinity binding. It should be noted
that the control R binding (100% in Tables 1 and  2) corresponded
to 40% of the subunits binding one molecule of cAMP. Thus, the
2.3 times increase obtained in clones 34 and 35 resulted in a total
occupancy of the cAMP binding site. A similar increase was also
observed for complete R/GFP fusion clones 101, 28, 89 and 33,
although in these cases, only a fraction of the molecules were
binding cAMP, possibly indicating a lower affinity than the
previous group. In contrast, clones 20, 59 and 37 increased cAMP
binding from five to 10 times when incubated at 500 nM cAMP
as compared with 50 nM cAMP, indicating that the insertion of
GFP resulted in a decrease of the affinity for cAMP. Extreme
cases from this last group were clones 20 and 59, which presented
a quasi-linear increase in binding up to the maximum concentration
tested (800 nM cAMP). As a whole, these results provided
evidence that the lower values of cAMP binding observed in a
number of R/GFP fusion proteins could at least in part be due to
lower affinities for cAMP.
We also verified that both cAMP binding and green fluorescence
were carried by the same polypeptide since green fluorescence was
retained on cAMP–agarose and eluted with cAMP (not shown).
This eliminates the possibility that in a given extract, subpopulations
of proteins with well-folded GFP but not having a functional R
subunit would co-exist with others displaying cAMP binding but not
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Figure 5. Model of the Dictyostelium R subunit showing GFP insertion sites.
Dictyostelium R subunit with bound cAMP was modelled using the program
Swiss-PdbViewer (18), based on the structure of the (∆1–91) R subunit from
mouse (14). Insertion sites are indicated by an arrow. (in) or (out) indicate that
the C-terminus of the R subunit is in-frame or out of frame with the inserted
GFP. cAMP bound to the R subunit are shown in solid sticks. Tyr197 is also
shown. The cAMP binding sites A and B are indicated by homology to the
structure presented in Su et al. (14).
having functional GFP. Clones 20, 37 and 59 did not bind
cAMP–agarose, which is likely due to their lower affinity for cAMP.
Finally, we tested whether the R/GFP fusion proteins were able to
inhibit PKA catalytic activity. From the 14 clones previously
presented, only clones 91, 58 and 33 inhibited the PKA activity
present in crude extracts of bacteria expressing the catalytic core
(C309) of the C subunit (data not shown). In all three cases,
inhibition was released by adding 50 µM cAMP. These results
indicate that the R–C interaction is not impaired by insertion of GFP
within the cAMP binding site B (Fig. 5), in agreement with previous
reports showing that deletion of site B up to Trp260 has no effect on
C subunit inhibition (15). The fact that R/GFP fusions 91, 58 and
33 show a different affinity for cAMP may allow sensitive
measurement over a broad range of cAMP concentrations within the
cell. In addition, our results underline the importance of the α-helix
connecting cAMP binding sites A and B, since C-terminal deletions
in clones 26, 34 and 35 result in a loss of interaction with the C
subunit, despite an ability to bind cAMP. Clone 89, in which GFP
is inserted in-frame, is impaired both in cAMP binding and R–C
interaction, further indicating the essential role of the α-helix in
between sites A and B.
In conclusion, we have developed a methodology for random
insertion of GFP within the coding region of a protein of interest.
This method enables the selection of fusion proteins where at least
the GFP is functional. Further studies on the R/GFP clones
indicated that, even though cAMP binding was lowered in many
instances, indicating a potential lower affinity, binding was
observed in all clones harbouring a GFP fused in-frame with the
R subunit. Twenty per cent of the R/GFP fusions were able to
interact with the C subunit in vitro. The lack of PKA inhibition by
R subunits presenting a GFP insertion within the α-helix present
at the end of the cAMP binding site A (clones 89, 26, 34 and 35)
further implicates a role for this region in the interaction between
R and C subunits. These results indicate that random insertion of
GFP can complement more thorough functional mapping.
GFP fusions at either ends of the R and C subunits from
mammals or Dictyostelium have previously been performed, but
no FRET could be measured (A.Kuspa and T.Pozzan, personal
communication). Even though fully in-frame GFP insertion did
not result in the isolation of R/GFP fusions having both high
fluorescence and high affinity for cAMP, the progressive
C-terminal deletions presented here offer a chance to place GFP
in closer proximity to another mutant GFP on the C subunit. This
process may provide a route to finally obtain intermolecular
FRET in a two-component system. The knowledge that GFP can
be randomly inserted while maintaining significant cAMP
binding by the R subunit, indicates that this type of approach
should also be possible for the C subunit. Furthermore, the
methodology presented herein could widen the spectrum of
approaches used to isolate partners for FRET and could further be
applied to proteins for which a crystal structure is not yet available.
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